Literature DB >> 27810685

Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: A survey research.

Javier Escalada1, Domingo Orozco-Beltran2, Carlos Morillas3, Fernando Alvarez-Guisasola4, Fernando Gomez-Peralta5, Manel Mata-Cases6, Rafael Palomares7, Rosario Iglesias8, Concepción Carratalá-Munuera9.   

Abstract

AIMS: To describe the views of healthcare providers about starting insulin in patients with type 2 diabetes and to determine the specific factors that contribute to delay insulin initiation.
METHODS: Two-phases observational descriptive study. In the quantitative phase we conducted a cross-sectional survey of a sample of 380 healthcare professionals (general practitioners (GPs), endocrinologists, internists and nurses). In the qualitative phase, a discussion group reviewed the results of the survey to propose solutions.
RESULTS: In poorly controlled patients, 46% of GPs vs. 43.2% of internists and 31.3% of endocrinologists waited 3-6months before starting insulin, and 71.4% of GPs vs. 66.7% of internists vs. 58.8% of endocrinologists need to confirm twice the HbA1c levels. The upper level of basal glucose more frequently considered as good control is 130mg/dL for GPs (35.7%), and 120mg/dL for internists (35.8%) and endocrinologists (37.5%). In patients without comorbidities, 32.5% of endocrinologists vs. 27.2% of internists vs. 17.9% of GPs initiated insulin when HbA1c was >7% while 26.3% of endocrinologists vs. 28.4% of internists vs. 38.4% of GPs initiated insulin when HbA1c was >8%. The interference of the therapy with the patient' social life and the need for time management were the most accepted barriers to initiate insulin.
CONCLUSIONS: There are significant differences between GPs and endocrinologists regarding the insulin initiation and GPs and internists felt less empowered to manage patients with diabetes. Specific training for professionals and joint work with patients could improve the glycemic control.
Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Disease management; General practice; Insulin; Time-to-treatments; Type 2

Mesh:

Substances:

Year:  2016        PMID: 27810685     DOI: 10.1016/j.diabres.2016.10.003

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study.

Authors:  Josep Franch-Nadal; Fermín García-Gollarte; Alfonso Pérez Del Molino; María L Orera-Peña; Marta Rodríguez de Miguel; Malena Melogno-Klinkas; Héctor D de Paz; Susana Aceituno; Patricia Rodríguez-Fortúnez
Journal:  Clin Drug Investig       Date:  2019-01       Impact factor: 2.859

Review 2.  100 years on: the impact of the discovery of insulin on clinical outcomes.

Authors:  John B Buse; Melanie J Davies; Brian M Frier; Athena Philis-Tsimikas
Journal:  BMJ Open Diabetes Res Care       Date:  2021-08

Review 3.  Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.

Authors:  Kamlesh Khunti; Marilia B Gomes; Stuart Pocock; Marina V Shestakova; Stéphane Pintat; Peter Fenici; Niklas Hammar; Jesús Medina
Journal:  Diabetes Obes Metab       Date:  2017-10-01       Impact factor: 6.577

4.  HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs.

Authors:  Andreas Fritsche; Helmut Anderten; Martin Pfohl; Stefan Pscherer; Anja Borck; Katrin Pegelow; Peter Bramlage; J Seufert
Journal:  BMJ Open Diabetes Res Care       Date:  2019-08-01

Review 5.  Identification of barriers to insulin therapy and approaches to overcoming them.

Authors:  David Russell-Jones; Frans Pouwer; Kamlesh Khunti
Journal:  Diabetes Obes Metab       Date:  2017-11-22       Impact factor: 6.577

6.  Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study.

Authors:  Irene Romera; Silvia Díaz; Antoni Sicras-Mainar; Flora López-Simarro; Tatiana Dilla; Esther Artime; Jesús Reviriego
Journal:  Diabetes Ther       Date:  2019-12-28       Impact factor: 2.945

7.  Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis.

Authors:  Rajesh R Mehta; Alison M Edwards; Swapnil Rajpathak; Ajay Sharma; Kenneth J Snow; Kristy Iglay
Journal:  J Clin Transl Endocrinol       Date:  2020-01-31

8.  Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.

Authors:  Harpreet S Bajaj; Richard M Bergenstal; Andreas Christoffersen; Melanie J Davies; Amoolya Gowda; Joakim Isendahl; Ildiko Lingvay; Peter A Senior; Robert J Silver; Roberto Trevisan; Julio Rosenstock
Journal:  Diabetes Care       Date:  2021-04-19       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.